Turnover: 212 million EUR (2022)
Country: France
Sebia, founded in 1967, specializes in the production of electrophoresis equipment, a technique used in in vitro diagnostic tests. The company has a major R&D center with 40 employees.
In 2017, the Bettencourt-Meyers family joined forces with several investment funds to take control of Sebia, which was valued at nearly 2 billion euros at the time.
Financial Data
DUNS: 672041902
Legal Name: SEBIA
Address: 27 RUE LEONARD DE VINCI PARC TECHNOLOGIQUE LEONARD DE VINCI, 91090 LISSES
Number of employees: 200-250 (2018)
Capital: 10 203 900
Financial Data:
| Year | Turnover (€) | Net Profit (€) | Fiscal Year End | Fiscal Year Duration |
|---|---|---|---|---|
| 2019 | 161 175 323 EUR | 64 107 316 EUR | 31/03/2019 | 12 |
| 2018 | 36 381 663 EUR | 14 131 034 EUR | 31/03/2018 | 3 |
| 2017 | 139 956 232 EUR | 65 044 978 EUR | 31/12/2017 | 12 |
| 2016 | 125 111 182 EUR | 57 761 034 EUR | 31/12/2016 | 12 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président du conseil d'administration | Jean-Marc Georges Daniel | CHERMETTE | 58 |
Studies mentioning this company
The in vitro diagnostics market - France
Other companies mentioned:
- Roche Groupe
- Diagast
- Abbott Groupe
- Danaher
- Thermo Fisher Diagnostics
- Sebia
- BioMerieux Groupe
- Diagnostica Stago
- Biosynex
- Diagnostic Medical System DMS Groupe